
Issue: Before the intervention, the organisation faced significant challenges stemming from scattered priorities and a top-heavy strategy. Leadership set numerous goals with limited focus and minimal input from operational teams, resulting in unclear ownership, weak accountability, and persistent gaps between strategic intent and effective execution.
Intervention: Catalystic introduced a structured alignment process that broadened strategic ownership beyond the executive layer. Strategy was democratized by empowering mid-tier (N-2) leaders to co-create the strategic roadmap, driving alignment and ownership across all levels. This roadmap was then translated into actionable annual operating plans, becoming a living guide with clear ownership and granular KPIs to track progress and ensure accountability.
Positioned among the Top 5 pharmaceutical companies in the market.
Before:
· Disconnected strategy, causing misalignment and silos.
· Lack of focus, weakening priorities and momentum.
· Execution gaps, limiting consistent results.
After:
· Clear goals, guiding decisions and direction.
· Aligned teams, collaborating toward shared outcomes.
· Measurable growth in sales and profitability, sustained and repeatable.